You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-Polycythemia Vera Myelofibrosis (PPV-MF)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

Recruiting
  • Polycythemia Vera
  • London, United Kingdom
  • +1 more
Nov 29, 2021

Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia:

Completed
  • Polycythemia Vera
  • +2 more
    • Salt Lake City, Utah
      University of Utah
    Oct 14, 2019

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +121 more
    Oct 21, 2021

    Polycythemia Vera Trial (bomedemstat)

    Not yet recruiting
    • Polycythemia Vera
    • (no location specified)
    Oct 24, 2022

    Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

    Recruiting
    • Polycythemia Vera
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    May 19, 2023

    Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Vienna, Austria
    • +19 more
    Apr 28, 2020

    Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

    Recruiting
    • Myeloproliferative Disorders
    • +4 more
    • La Jolla, California
    • +184 more
    Aug 22, 2022

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Completed
    • Primary Myelofibrosis
    • +2 more
    • Phoenix, Arizona
    • +113 more
    Apr 13, 2020

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Berkeley, California
    • +176 more
    Dec 1, 2022

    Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

    Withdrawn
    • Myelofibrosis Transformation in Essential Thrombocythemia
    • +2 more
    • LOXL2 Inhibitor PAT-1251
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2019

    Philadelphia Negative Myeloproliferative Tumors Trial

    Not yet recruiting
    • Philadelphia Negative Myeloproliferative Neoplasms
      • (no location specified)
      Jun 5, 2022

      Primary Myelofibrosis (MF), Post-Polycythemia Vera (PV) MF, Post-Essential Thrombocythemia (ET) MF Trial in Worldwide

      Completed
      Has Results
      • Primary Myelofibrosis (MF)
      • +2 more
      • Beijing, Beijing, China
      • +25 more
      Aug 29, 2019

      Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

      Recruiting
      • Myelofibrosis
      • Hematopoietic Stem Cell Transplant
      • Minneapolis, Minnesota
        Center for International Blood and Marrow Transplant Research
      Mar 17, 2022

      Ruxolitinib for Polycythemia Vera in Patients Resistant to or

      Completed
      • Polycythemia Vera (PV)
      • Ruxolitinib
      • East Hanover, New Jersey
        Novartis Investigative Site
      Jun 29, 2022

      Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

      Completed
      • Adherence, Patient
      • Adherence, Treatment
        • Cosenza, Calabria, Italy
        • +27 more
        Oct 11, 2023

        Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

        Terminated
        Has Results
        • Primary Myelofibrosis
        • +2 more
        • Scottsdale, Arizona
        • +80 more
        Sep 25, 2020

        Myelofibrosis (MF) Trial in Worldwide (Ruxolitinib, Navitoclax)

        Active, not recruiting
        • Myelofibrosis (MF)
        • Birmingham, Alabama
        • +149 more
        Nov 5, 2021

        Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (CC-4047)

        Completed
        Has Results
        • Chronic Myeloproliferative Disorders
        • Secondary Myelofibrosis
        • Rochester, Minnesota
          Mayo Clinic
        Dec 16, 2019

        Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)

        Active, not recruiting
        • Chronic Myeloproliferative Neoplasms
        • Berlin, Germany
        • +14 more
        Jun 14, 2021

        Myeloproliferative Tumors (MPN), Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Toronto (Upper gastrointestinal

        Completed
        • Myeloproliferative Neoplasms (MPN)
        • +3 more
        • Upper gastrointestinal endoscopy and Doppler ultrasound
        • Toronto, Ontario, Canada
        • +1 more
        Dec 12, 2019

        Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis Trial in Chicago (Durvalumab, Laboratory

        Withdrawn
        • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
        • Primary Myelofibrosis
        • Durvalumab
        • Laboratory Biomarker Analysis
        • Chicago, Illinois
          Northwestern University
        Aug 16, 2019

        ARDS, Human, COVID Trial in Marburg (Ruxolitinib administration)

        Completed
        • ARDS, Human
        • COVID
        • Ruxolitinib administration
        • Marburg, Germany
          Andreas Neubauer
        Aug 23, 2021

        Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)

        Completed
        Has Results
        • Primary Myelofibrosis
        • +9 more
        • Camperdown, New South Wales, Australia
        • +17 more
        Apr 3, 2020

        Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

        Recruiting
        • Myelofibrosis
        • +3 more
        • Birmingham, Alabama
        • +13 more
        Jan 10, 2023